HIV Clinical Topics in Antiretroviral Therapy 2025

Josep M Llibre, MD, PhD, received his MD in the Universitat de Barcelona, and obtained his specialty in Internal Medicine and his PhD in the Universitat Autònoma de Barcelona. He is a member of the panel of Antiretroviral treatment guidelines at the GeSIDA group (AIDS group of the SEIMC Spanish society), and an expert advisor of the Catalan Health Institute (ICS) on antiretroviral treatment and hepatitis C (PADEICS). He started caring for patients with HIV/AIDS at the beginning of the epidemic in Spain in 1987. His main areas of interest in HIV Medicine include the clinical implications of HIV-1 resistance, the analysis of safety and efficacy in HIV-1 antiretroviral treatment clinical trials (both in naïve and pre-treated patients), with a special interest in drug efficacy and pharmacoeconomics, and hepatitis C co-infection. He has published widely in journals and book chapters, as well as HIV/AIDS medical webs, on clinical aspects of HIV-1 treatment and care, HIV-1 resistance, clinical reviews, positioning papers, treatment intensification and simplification strategies, and participated in many pivotal clinical trials. He has also published in basic science research journals. He collaborates as an editor and/or peer-reviewing with many top international medical journals. He is involved in HIV Medical Educational training in Spain and other European, as well as Asian Countries.

Cristina Mussini has been Full Professor of Infectious Diseases at the University of Modena and Reggio Emilia in Italy since 2011. She is also the Director of the Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico, in Modena, Italy. She received her degree in medicine and surgery from the University of Modena in 1987 and completed a specialization in infectious diseases in 1990.

Cristina has published more than 200 papers in index journals with a total of above 900 and with an H-index of 55 (Google Scholar).

Cristina is a long-standing member of several organizations, including: the National AIDS Committee of the Italian Ministry of Health from 2009 to 2016; the Governing Board of the European AIDS Clinical Society since 2000; and the Scientific Committees for the European AIDS Conferences, HIV Glasgow and the Icona Cohort Study since 2008. She is Chair of the ESGIE, the ESCMID Study Group for Infections in the Elderly.

University of Bonn, Germany

Georg Behrens is Professor for T Cell Immunology at Hannover Medical School, Germany. He is specialist in internal medicine, immunology and infectious disease and trained at the Immunology Division at the Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia.

He is principal investigator of national and international studies in HIV medicine and was president of the German AIDS Society from 2011-2019. For many years, we was Board Member of the European AIDS Clinical Society (EACS) and chair of the EACS Treatment Guidelines. He is NEAT-ID steering committee member, co-chair of the TTU-HIV within the German Center for Infection Research (DZIF), and chair of the MD/PhD Program Molecular Medicine.

Dr. Jose I Bernardino is a Consultant Physician in HIV Medicine and Infectious diseases at the Hospital Universitario La Paz. He is member of the High-level Isolation Unit of La Paz- Carlos III Hospital. He is member of the faculty of the Young Investigators Group of the European AIDS Clinical Society (EACS), and member of the Europeans AIDS Trial network NEAT-ID and International Network for Strategic Initiatives in Global HIV trials (INSIGHT). He is author of more than 90 publications in peer-reviewed journals, including original articles, and commentaries. His fields of interests span antiretroviral therapy strategies, ART toxicity, non-infectious complications and comorbidities in HIV positive adults and aging.

Adrià Curran is a staff physician of the Infectious Diseases Department and the coordinator of the Anal Dysplasia Screening Unit of Vall d’Hebron University Hospital. He has carried out specific training on HPV anal dysplasia in HIV patients at the University of San Francisco (CA, USA) with Prof. Joel Palefsky. He is a member of the International Anal Neoplasia Society. He participates as a researcher in multiple international clinical trials and has published more than 100 articles in national and international journals and book chapters on various aspects of HIV infection, HPV and its treatment.

Susanne Dam Poulsen is professor of infectious diseases at Department of Infectious Diseases, University of Copenhagen Rigshospitalet. She has worked with HIV, inflammation, and immunology for since 1994, and the last decade she has focused on HIV-related comorbidities, including CVD and chronic lung diseases. She leads a research team that studies HIV-related comorbidities, and she is the PI of the Copenhagen Comorbidity in HIV (COCOMO) study. She is the co-author of more than 300 scientific publications, and she has mentored 32 PhD students.
Since 2023 Susanne Dam Poulsen has been the co-chair of the European AIDS Clinical Society (EACS) HIV comorbidities guideline panel.

Dr. Gandhi is a Professor of Medicine at Harvard Medical School, and Director of HIV Clinical Services and Education at Massachusetts General Hospital (MGH). Dr. Gandhi is  site leader of the MGH AIDS Clinical Research Site in the AIDS Clinical Trials Group (ACTG). He is also the Co-Director and Principal Investigator of the Harvard University Center for AIDS Research (CFAR). Dr. Gandhi is a member of the NIH COVID-19 Treatment Guidelines Panel and the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guidelines Panel. He is also a scientific member of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, and Chair of the International Antiviral Society-USA Panel on Antiretroviral Drugs for Treatment and Prevention of HIV in Adults. Dr. Gandhi is Editor-in-Chief of NEJM Journal Watch Infectious Diseases. Dr. Gandhi graduated from Harvard Medical School, completed his medical residency and chief residency at Brigham and Women’s Hospital, and his infectious diseases fellowship training at Johns Hopkins Hospital.  He has been on the faculty of the Infectious Diseases Division at MGH since 2000.

Dr. Nicolo Girometti is a consultant physician in HIV and sexual health at 56 Dean Street, Chelsea and Westminster Hospital (London, UK). He obtained his specialist degree in infectious diseases and HIV medicine at Bologna University (Bologna, Italy). He has a research interest in HIV prevention strategies and ageing in people living with HIV.

Ole Kirk has been an ID consultant since 2011 and works at Rigshospitalet, Copenhagen, Denmark, sharing his time between an ID in-patient ward and a HIV out-patient ward. He is also an adjunct professor in infectious diseases at University of Southern Denmark.

Since 1997, Ole has been engaged in HIV medicine and European research activities, in particular in management of the EuroSIDA Study, but also in other large cohort collaborations such as the DAD Study and COHERE. Since 2006, he has coordinated the TB-HIV Studies including 62 sites in Latin America, Western Europe and Eastern Europe.

Ole has published approximately 200 articles, mainly within research areas such HIV epidemiology, uptake of and response to ART across Europe as well as toxicity to ART, often with a perspective of regional differences across Europe. Another research priority has been HIV and opportunistic infections. In recent years he has been focusing on special clinical issues for PLWH in Eastern Europe, and in particular tuberculosis.

Ole is present chair of the OI panel of EACS Guidelines Committee and has over the last 15 years been actively involved in teaching activities for HIV clinicians, with special focus on colleagues in Eastern Europe. This includes organizing local HIV seminars, participating in WHO mentoring programmes for Ukrainian clinicians and running monthly videoconferences for HIV clinicians in Georgia and Ukraine.

In Denmark, Ole has been organizing and leading post-graduate courses of HIV infection and HIV care for Danish ID clinicians since 2013, and he is present chair of the Danish Society of Infectious Diseases.

Dr Maud Lemoine is Professor and Honorary Consultant in Hepatology at St Mary’s hospital, Imperial College London, UK. She completed her medical degree and PhD in Paris, France. She also graduated in political sciences from the Institute of Political Studies in Paris. Her research activities are mainly focused on the prevention and management of viral hepatitis in resource-limited countries, mainly in Africa. Since 2011, she has been working with the Medical Research Council (MRC) The Gambia unit, as part of the hepatitisB PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa) programme in The Gambia and Senegal. She has been member of the WHO guideline development group for the management of chronic hepatitis B/C and is regularly commissioned by the WHO viral hepatitis unit for external reviews and consultancies

Teymur Noori is a psychologist and works at the European Centre for Disease Prevention and Control (ECDC) as an expert on monitoring and evaluation. He is primarily responsible for monitoring the HIV response in Europe and Central Asia, including monitoring the continuum of HIV care and supporting efforts to monitor the response to viral hepatitis in the EU/EEA. He has recently led efforts to develop a monitoring and evaluation framework for COVID-19 surveillance, preparedness and response indicators in the EU/EEA. Teymur is also leading ECDC work on migrant health and infectious diseases. He recently led ECDC work to develop guidance on screening and vaccination of infectious diseases among newly arrived migrants in the EU/EEA as well as guidance on infection prevention and control of COVID-19 in migrant and refugee reception centres in the EU/EEA.

Dr. Silvia Nozza holds a medical degree from the University of Milan (Italy) and completed her specialization in infectious diseases in November 2004. She works at the outpatient HIV clinic at San Raffaele Hospital. She participates in various clinical trials focusing on the treatment and prevention of HIV, and more recently, COVID-19. She is the principal investigator of several projects funded by the Italian government. Dr. Nozza is also an advisory professor at the University Vita-Salute San Raffaele. Additionally, she is a member of the editorial board for the Italian guidelines on HIV diagnosis and treatment.

Cristiana Oprea MD, Ph.D. is Associate Professor at Carol Davila University of Medicine and Pharmacy in Bucharest, a practicing specialist in infectious diseases and the Head of the Clinical Infectious diseases Department I at “Victor Babes” Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Since 1993, the peak of the paediatric HIV epidemic in Romania, Dr Oprea has been actively involved in the management and treatment of children belonging to the Romanian HIV paediatric cohort (infected by parenteral mode in their first years of life, in the late ‘80s), continuing with adolescents and young adults, then facing the new HIV epidemic in injecting drug users and MSM and the increase in HIV/TB cases.Dr Oprea’s research interest is focused on HIV and opportunistic infections, co-infections with viral hepatitis, HIV in women and MTCT of HIV, and Standards of care for HIV and Co-infections in Central and Eastern Europe.

Dr Oprea was involved in research projects and clinical trials on treatment of HIV and hepatitis and in PENTA. She is a member of EuroSIDA Steering Committee and of the scientific committee of WAVE (women against viruses in Europe). She was part of the European AIDS Clinical Society (EACS) Governing board between 2014-2024 and of the scientific committee of ECCMID between 2018-2022. She is currently chair of the panel of opportunistic infections section for the EACS guidelines and co-chair of the EACS Standard of care meeting for HIV and coinfections.

Maria Santoro is an associate professor at the Laboratory of Virology, Department of Experimental Medicine, Faculty of Medicine, University of Rome “Tor Vergata”. She obtained the PhD in Microbiology and Medical Immunology at the University of Rome “Tor Vergata”, in 2006. She has been involved in research activity on viruses since 2002.

Her research interests focus on HIV infection and epidemiology, antiviral drugs, HIV/HBV/HCV drug-resistance, viral pathogenesis, viral tropism, viral evolution and dynamics, molecular diagnostics, structural and functional analysis of viral proteins.

She is a member of the steering committee of: the Italian Cohort of Antiretroviral-Naïve Patients (ICONA) Foundation; the scientific committee of the Antiviral Response Cohort Analysis (ARCA) database; the Italian PRESTIGIO (Pazienti con Infezione da HIV-1 con RESistenza agli Inibitori della Trascrittasi inversa, dell’InteGrasI e della PrOteasi virale) Registry. She was a member of the panel of the Italian guidelines for the management of HIV-1 infected patients (2012–2017).

She cooperates with many nationally and internationally recognised scientific researchers in several grants from the Italian National Institute of Health, the Ministry of University and Scientific Research, and the European Community.

Infectious Diseases Specialist, both in outpatient and inpatient settings. Infectious Diseases teacher in Lisbon School of Medicine, University of Lisbon.

Specialist in Endocrinology and Nutrition at the Bellvitge University Hospital-IDIBELL, coordinator of the Severe Obesity Program there. Associate Professor at the University of Barcelona. Member of the CIBERDEM Network (CIBER for Diabetes and Associated Metabolic Diseases). Principal investigator of several FIS grants whose research focuses on the study of severe obesity and bariatric surgery. Other qualifications include: Research Member of the SEEN (Spanish Society of Endocrinology and Nutrition) and member of the steering committee of the Obesity knowledge area of ​​the Spanish Society of Endocrinology and Nutrition.

Dr Gary Whitlock is a consultant physician in HIV and sexual health and Service Director at 56 Dean Street, part of Chelsea and Westminster Hospital. Dr Whitlock has a PhD in physiology from the University of Cambridge and qualified from Nottingham University in medicine.

He runs the high-resolution anoscopy service at 56 Dean Street. His research interests include gay men’s sexual health, HIV prevention and service evaluation.